{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:32:52Z","timestamp":1792481572434,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sarcoidosis is a systemic granulomatous disease of unknown etiology. Clinical cohort studies of different populations are important to understand the high variability in clinical presentation and disease course of sarcoidosis. The aim of the study is to evaluate clinical characteristics, including organ involvement, pulmonary function tests, and laboratory parameters, in a sarcoidosis cohort at the University of Minnesota. We compare the organ system involvement of this cohort with other available cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective data collection and analysis of 187 subjects with biopsy-proven sarcoidosis seen at a tertiary center. Organ system involvement was determined using the WASOG sarcoidosis organ assessment instrument. Clinical phenotype groups were classified using the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis criteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Mean subject age at diagnosis was 45.8\u2009\u00b1\u200912.4, with a higher proportion of males (55.1%), and a higher proportion of blacks (17.1%) compared to the racial distribution of Minnesota residents (5.95%). The majority (71.1%) of subjects required anti-inflammatory therapy for at least 1\u2009month. Compared to the A Case Control Etiologic Study of Sarcoidosis cohort, there was a higher frequency of extra-thoracic lymph node (34.2% vs. 15.2%), eye (20.9% vs. 11.8%), liver (17.6% vs. 11.5%), spleen (20.9% vs. 6.7%), musculoskeletal (9.6% vs. 0.5%), and cardiac (10.7% vs. 2.3%) involvement in our cohort. A multisystem disease with at least five different organs involved was identified in 13.4% of subjects. A restrictive physiological pattern was observed in 21.6% of subjects, followed by an obstructive pattern in 17.3% and mixed obstructive and restrictive pattern in 2.2%. Almost half (49.2%) were Scadding stages II\/III. Commonly employed disease activity markers, including soluble interleukin-2 receptor and angiotensin-converting enzyme, did not differ between treated and untreated groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This cohort features a relatively high frequency of high-risk sarcoidosis phenotypes including cardiac and multiorgan disease. Commonly-utilized serum biomarkers do not identify subpopulations that require or do better with treatment. Findings from this study further\u00a0highlight the high-variability nature of sarcoidosis and the need for a more reliable biomarker to predict and measure disease severity and outcomes for better clinical management of\u00a0sarcoidosis patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-020-01191-x","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T14:05:26Z","timestamp":1591106726000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts"],"prefix":"10.1186","volume":"20","author":[{"given":"Hok Sreng","family":"Te","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Steinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J.","family":"Cogswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Roukoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik J.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi L.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1294-6181","authenticated-orcid":false,"given":"Maneesh","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,1]]},"reference":[{"key":"1191_CR1","unstructured":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736\u201355."},{"issue":"5","key":"1191_CR2","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/MCP.0000000000000080","volume":"20","author":"AK Gerke","year":"2014","unstructured":"Gerke AK. Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med. 2014;20(5):472\u20138.","journal-title":"Curr Opin Pulm Med"},{"issue":"Supplement_6","key":"1191_CR3","doi-asserted-by":"publisher","first-page":"S421","DOI":"10.1513\/AnnalsATS.201707-564OT","volume":"14","author":"AK Gerke","year":"2017","unstructured":"Gerke AK, Judson MA, Cozier YC, Culver DA, Koth LL. Disease Burden and Variability in Sarcoidosis. Ann Am Thorac Soc. 2017;14(Supplement_6):S421\u20138.","journal-title":"Ann Am Thorac Soc"},{"issue":"9923","key":"1191_CR4","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155\u201367.","journal-title":"Lancet"},{"issue":"6","key":"1191_CR5","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.rmed.2012.02.007","volume":"106","author":"BS Erdal","year":"2012","unstructured":"Erdal BS, Clymer BD, Yildiz VO, Julian MW, Crouser ED. Unexpectedly high prevalence of sarcoidosis in a representative U.S. metropolitan population. Respir Med. 2012;106(6):893\u20139.","journal-title":"Respir Med"},{"issue":"17","key":"1191_CR6","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","volume":"336","author":"LS Newman","year":"1997","unstructured":"Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336(17):1224\u201334.","journal-title":"N Engl J Med"},{"issue":"3","key":"1191_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","volume":"145","author":"BA Rybicki","year":"1997","unstructured":"Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234\u201341.","journal-title":"Am J Epidemiol"},{"issue":"21","key":"1191_CR8","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1056\/NEJMra071714","volume":"357","author":"MC Iannuzzi","year":"2007","unstructured":"Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153\u201365.","journal-title":"N Engl J Med"},{"issue":"2","key":"1191_CR9","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1378\/chest.14-1120","volume":"147","author":"M Mirsaeidi","year":"2015","unstructured":"Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015;147(2):438\u201349.","journal-title":"Chest"},{"issue":"11","key":"1191_CR10","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","volume":"183","author":"JJ Swigris","year":"2011","unstructured":"Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, Brown KK. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011;183(11):1524\u201330.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10 Pt 1","key":"1191_CR11","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","volume":"164","author":"RP Baughman","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"1191_CR12","doi-asserted-by":"crossref","unstructured":"Sauer WH, Stern BJ, Baughman R, Culver DA, Royal W. High risk Sarcoidosis: current concepts and research imperatives. Ann Am Thorac Soc. 2017;14 (Supplement_6):S437\u2013S444.","DOI":"10.1513\/AnnalsATS.201707-566OT"},{"issue":"1","key":"1191_CR13","first-page":"26","volume":"11","author":"K Iwai","year":"1994","unstructured":"Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP, Maheshwari A, Noguchi TI. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis. 1994;11(1):26\u201331.","journal-title":"Sarcoidosis"},{"key":"1191_CR14","unstructured":"Brown F, Tanner LS. Lofgren Syndrome. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2020. PMID: 29493940."},{"issue":"1","key":"1191_CR15","first-page":"75","volume":"16","author":"MA Judson","year":"1999","unstructured":"Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS research group. A Case control etiologic study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999;16(1):75\u201386.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1","key":"1191_CR16","first-page":"33","volume":"67","author":"DL Carrillo-Perez","year":"2015","unstructured":"Carrillo-Perez DL, Apodaca-Chaveza EI, Carrillo-Maravilla E, Mejia-Avila M, Hernandez-Oropeza JL, Reyes E, Atisha-Fregoso Y, Hernandez-Molina G. Sarcoidosis: a single hospital-based study in a 24-year period. Rev Investig Clin. 2015;67(1):33\u20138.","journal-title":"Rev Investig Clin"},{"issue":"4","key":"1191_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00408-017-0015-4","volume":"195","author":"N Markevitz","year":"2017","unstructured":"Markevitz N, Epstein Shochet G, Levi Y, Israeli-Shani L, Shitrit D. Sarcoidosis in Israel: clinical outcome status, organ involvement, and long-term follow-up. Lung. 2017;195(4):419\u201324.","journal-title":"Lung"},{"issue":"1","key":"1191_CR18","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, et al. The WASOG Sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(1):19\u201327.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"10","key":"1191_CR19","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1513\/AnnalsATS.201503-172OT","volume":"12","author":"DR Moller","year":"2015","unstructured":"Moller DR, Koth LL, Maier LA, Morris A, Drake W, Rossman M, Leader JK, Collman RG, Hamzeh N, Sweiss NJ, et al. Rationale and Design of the Genomic Research in Alpha-1 antitrypsin deficiency and Sarcoidosis (GRADS) study. Sarcoidosis Protocol. Ann Am Thorac Soc. 2015;12(10):1561\u201371.","journal-title":"Ann Am Thorac Soc"},{"key":"1191_CR20","unstructured":"Minnesota Population 2019. https:\/\/data.census.gov\/cedsci\/table?g=0100000US_0400000US27&tid=ACSDT5Y2017.B04006&q=B04006."},{"key":"1191_CR21","unstructured":"2013\u20132017 American Community Survey 5-Year Estimates. In.: US Census Bureau; 2017. (data.census.gov)."},{"issue":"5","key":"1191_CR22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","volume":"195","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD executive summary. Am J Respir Crit Care Med. 2017;195(5):557\u201382.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"1191_CR23","doi-asserted-by":"publisher","first-page":"e007488","DOI":"10.1161\/CIRCEP.119.007488","volume":"12","author":"F Kazmirczak","year":"2019","unstructured":"Kazmirczak F, Chen KA, Adabag S, von Wald L, Roukoz H, Benditt DG, Okasha O, Farzaneh-Far A, Markowitz J, Nijjar PS, et al. Assessment of the 2017 AHA\/ACC\/HRS guideline recommendations for implantable Cardioverter-defibrillator implantation in cardiac Sarcoidosis. Circ Arrhythm Electrophysiol. 2019;12(9):e007488.","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"1191_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4081\/reumatismo.2017.965","volume":"69","author":"P Ungprasert","year":"2017","unstructured":"Ungprasert P, Crowson CS, Matteson EL. Epidemiology and clinical characteristics of sarcoidosis: an update from a population-based cohort study from Olmsted County, Minnesota. Reumatismo. 2017;69(1):16\u201322.","journal-title":"Reumatismo"},{"issue":"5","key":"1191_CR25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00408-017-0037-y","volume":"195","author":"BS Benn","year":"2017","unstructured":"Benn BS, Lehman Z, Kidd SA, Ho M, Sun S, Ramstein J, Arger NK, Nguyen CP, Su R, Gomez A, et al. Clinical and biological insights from the University of California san Francisco prospective and longitudinal cohort. Lung. 2017;195(5):553\u201361.","journal-title":"Lung"},{"key":"1191_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.rmed.2019.03.012","volume":"152","author":"MA Judson","year":"2019","unstructured":"Judson MA, Preston S, Hu K, Zhang R, Jou S, Modi A, Sukhu I, Ilyas F, Rosoklija G, Yucel R. Quantifying the relationship between symptoms at presentation and the prognosis of sarcoidosis. Respir Med. 2019;152:14\u20139.","journal-title":"Respir Med"},{"issue":"4","key":"1191_CR27","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1183\/09031936.00039714","volume":"44","author":"R Su","year":"2014","unstructured":"Su R, Li MM, Bhakta NR, Solberg OD, Darnell EP, Ramstein J, Garudadri S, Ho M, Woodruff PG, Koth LL. Longitudinal analysis of sarcoidosis blood transcriptomic signatures and disease outcomes. Eur Respir J. 2014;44(4):985\u201393.","journal-title":"Eur Respir J"},{"key":"1191_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.rmed.2019.04.005","volume":"152","author":"NK Arger","year":"2019","unstructured":"Arger NK, Ho M, Woodruff PG, Koth LL. Serum CXCL11 correlates with pulmonary outcomes and disease burden in sarcoidosis. Respir Med. 2019;152:89\u201396.","journal-title":"Respir Med"},{"issue":"8","key":"1191_CR29","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.21037\/jtd.2016.06.39","volume":"8","author":"C Chenivesse","year":"2016","unstructured":"Chenivesse C, Boulanger S, Langlois C, Wemeau-Stervinou L, Perez T, Wallaert B. Oxygen desaturation during a 6-minute walk test as a predictor of maximal exercise-induced gas exchange abnormalities in sarcoidosis. J Thorac Dis. 2016;8(8):1995\u20132003.","journal-title":"J Thorac Dis"},{"issue":"1","key":"1191_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1378\/chest.06-2822","volume":"132","author":"RP Baughman","year":"2007","unstructured":"Baughman RP, Sparkman BK, Lower EE. Six-minute walk test and health status assessment in sarcoidosis. Chest. 2007;132(1):207\u201313.","journal-title":"Chest"},{"issue":"1","key":"1191_CR31","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2018-000394","volume":"6","author":"NA Kampstra","year":"2019","unstructured":"Kampstra NA, Grutters JC, van Beek FT, Culver DA, Baughman RP, Renzoni EA, Wuyts W, Kouranos V, Wijsenbeek MS, Biesma DH, et al. First patient-centred set of outcomes for pulmonary sarcoidosis: a multicentre initiative. BMJ Open Respir Res. 2019;6(1):e000394.","journal-title":"BMJ Open Respir Res"},{"key":"1191_CR32","doi-asserted-by":"crossref","unstructured":"Maier LA, Crouser ED, Martin WJ, Eu J: Executive summary of the NHLBI Workshop Report: Leveraging Current Scientific Advances to Better Understand Sarcoidosis Variability and Improve Outcomes. Ann Am Thorac Soc 2017.","DOI":"10.1513\/AnnalsATS.201707-563OT"},{"key":"1191_CR33","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1749-6632.1976.tb47058.x","volume":"278","author":"Y Matsui","year":"1976","unstructured":"Matsui Y, Iwai K, Tachibana T, Fruie T, Shigematsu N, Izumi T, Homma AH, Mikami R, Hongo O, Hiraga Y, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci. 1976;278:455\u201369.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1191_CR34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/0002-9343(77)90121-8","volume":"63","author":"WC Roberts","year":"1977","unstructured":"Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med. 1977;63(1):86\u2013108.","journal-title":"Am J Med"},{"issue":"6","key":"1191_CR35","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","volume":"58","author":"KJ Silverman","year":"1978","unstructured":"Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation. 1978;58(6):1204\u201311.","journal-title":"Circulation"},{"issue":"11","key":"1191_CR36","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/eurjhf\/hfr099","volume":"13","author":"AR Patel","year":"2011","unstructured":"Patel AR, Klein MR, Chandra S, Spencer KT, Decara JM, Lang RM, Burke MC, Garrity ER, Hogarth DK, Archer SL, et al. Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study. Eur J Heart Fail. 2011;13(11):1231\u20137.","journal-title":"Eur J Heart Fail"},{"issue":"10 Pt A","key":"1191_CR37","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.jcmg.2017.08.005","volume":"10","author":"AR Patel","year":"2017","unstructured":"Patel AR, Kramer CM. Role of Cardiac Magnetic Resonance in the Diagnosis and Prognosis of Nonischemic Cardiomyopathy. JACC Cardiovasc Imaging. 2017;10(10 Pt A):1180\u201393.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"20","key":"1191_CR38","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","volume":"120","author":"MR Patel","year":"2009","unstructured":"Patel MR, Cawley PJ, Heitner JF, Klem I, Parker MA, Jaroudi WA, Meine TJ, White JB, Elliott MD, Kim HW, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation. 2009;120(20):1969\u201377.","journal-title":"Circulation"},{"issue":"5","key":"1191_CR39","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/j.1540-8167.2008.01417.x","volume":"20","author":"K Soejima","year":"2009","unstructured":"Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol. 2009;20(5):578\u201383.","journal-title":"J Cardiovasc Electrophysiol"},{"issue":"7","key":"1191_CR40","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305\u201323.","journal-title":"Heart Rhythm"},{"key":"1191_CR41","doi-asserted-by":"crossref","unstructured":"Fumio Terasaki KY. New guidelines for diagnosis of cardiac Sarcoidosis in Japan. Ann Nucl Cardiol. 2017.","DOI":"10.17996\/anc.17-00042"},{"issue":"10","key":"1191_CR42","doi-asserted-by":"publisher","first-page":"e011253","DOI":"10.1161\/JAHA.118.011253","volume":"8","author":"O Okasha","year":"2019","unstructured":"Okasha O, Kazmirczak F, Chen KA, Farzaneh-Far A, Shenoy C. Myocardial involvement in patients with histologically diagnosed cardiac Sarcoidosis: a systematic review and meta-analysis of gross pathological images from autopsy or cardiac transplantation cases. J Am Heart Assoc. 2019;8(10):e011253.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"1191_CR43","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s12350-015-0199-z","volume":"22","author":"M Cerqueira","year":"2015","unstructured":"Cerqueira M, Case J, Maddahi J. Proceedings of the ASNC cardiac PET summit meeting, May 12, 2014, Baltimore MD : 5. Advances in radiopharmaceutical availability and development of cardiac PET tracers. J Nucl Cardiol. 2015;22(4):730\u20139.","journal-title":"J Nucl Cardiol"},{"key":"1191_CR44","doi-asserted-by":"crossref","unstructured":"Slart R, Glaudemans A, Lancellotti P, Hyafil F, Blankstein R, Schwartz RG, Jaber WA, Russell R, Gimelli A, Rouzet F, et al. A joint procedural position statement on imaging in cardiac sarcoidosis: from the cardiovascular and Inflammation & Infection Committees of the European Association of Nuclear Medicine, the European Association of Cardiovascular Imaging, and the American society of nuclear cardiology. J Nucl Cardiol. 2017.","DOI":"10.1007\/s12350-017-1043-4"},{"key":"1191_CR45","doi-asserted-by":"crossref","unstructured":"Ribeiro Neto ML, Jellis CL, Joyce E, Callahan TD, Hachamovitch R, Culver DA. Update on Cardiac Sarcoidosis. Ann Am Thorac Soc. 2019.","DOI":"10.1513\/AnnalsATS.201902-119CME"},{"key":"1191_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.rmed.2016.02.011","volume":"113","author":"MA Judson","year":"2016","unstructured":"Judson MA. The three tiers of screening for sarcoidosis organ involvement. Respir Med. 2016;113:42\u20139.","journal-title":"Respir Med"},{"issue":"2","key":"1191_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1080\/20009666.2019.1575688","volume":"9","author":"JI Pena-Garcia","year":"2019","unstructured":"Pena-Garcia JI, Shaikh S, Barakoti B, Papageorgiou C, Lacasse A. Bone marrow involvement in sarcoidosis: an elusive extrapulmonary manifestation. J Community Hosp Intern Med Perspect. 2019;9(2):150\u20134.","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"4","key":"1191_CR48","first-page":"419","volume":"32","author":"H Yanardag","year":"2002","unstructured":"Yanardag H, Pamuk GE, Karayel T, Demirci S. Bone marrow involvement in sarcoidosis: an analysis of 50 bone marrow samples. Haematologia (Budap). 2002;32(4):419\u201325.","journal-title":"Haematologia (Budap)"},{"issue":"8","key":"1191_CR49","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1182\/blood.V11.8.720.720","volume":"11","author":"GL Pease","year":"1956","unstructured":"Pease GL. Granulomatous lesions in bone marrow. Blood. 1956;11(8):720\u201334.","journal-title":"Blood"},{"issue":"5\u20136","key":"1191_CR50","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2298\/SARH1506279P","volume":"143","author":"Z Pavlovic-Popovic","year":"2015","unstructured":"Pavlovic-Popovic Z, Zaric B, Kosjerina Z, Petrovic D. Splenomegaly in Sarcoidosis: frequency, treatment, prognosis and long-term follow-up. Srp Arh Celok Lek. 2015;143(5\u20136):279\u201383.","journal-title":"Srp Arh Celok Lek"},{"issue":"10","key":"1191_CR51","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1136\/bjophthalmol-2015-307455","volume":"100","author":"NP Jones","year":"2016","unstructured":"Jones NP, Tsierkezou L, Patton N. Lymphopenia as a predictor of sarcoidosis in patients with uveitis. Br J Ophthalmol. 2016;100(10):1393\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"1191_CR52","doi-asserted-by":"publisher","first-page":"e9088","DOI":"10.1371\/journal.pone.0009088","volume":"5","author":"NJ Sweiss","year":"2010","unstructured":"Sweiss NJ, Salloum R, Gandhi S, Alegre ML, Sawaqed R, Badaracco M, Pursell K, Pitrak D, Baughman RP, Moller DR, et al. Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations. PLoS One. 2010;5(2):e9088.","journal-title":"PLoS One"},{"issue":"36","key":"1191_CR53","doi-asserted-by":"publisher","first-page":"e12205","DOI":"10.1097\/MD.0000000000012205","volume":"97","author":"J Duan","year":"2018","unstructured":"Duan J, Xu Y, Zhu H, Zhang H, Sun S, Sun H, Wang W, Xie S. Relationship between CT activity score with lung function and the serum angiotensin converting enzyme in pulmonary sarcoidosis on chest HRCT. Medicine (Baltimore). 2018;97(36):e12205.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1191_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00408-015-9826-3","volume":"194","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Carmona EM, Crowson CS, Matteson EL. Diagnostic utility of angiotensin-converting enzyme in Sarcoidosis: a population-based study. Lung. 2016;194(1):91\u20135.","journal-title":"Lung"},{"issue":"5","key":"1191_CR55","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1164\/ajrccm.156.5.97-02050","volume":"156","author":"MW Ziegenhagen","year":"1997","unstructured":"Ziegenhagen MW, Benner UK, Zissel G, Zabel P, Schlaak M, Muller-Quernheim J. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med. 1997;156(5):1586\u201392.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1191_CR56","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1378\/chest.09-1975","volume":"137","author":"S Miyoshi","year":"2010","unstructured":"Miyoshi S, Hamada H, Kadowaki T, Hamaguchi N, Ito R, Irifune K, Higaki J. Comparative evaluation of serum markers in pulmonary sarcoidosis. Chest. 2010;137(6):1391\u20137.","journal-title":"Chest"},{"issue":"8","key":"1191_CR57","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1093\/ajcn\/33.8.1828","volume":"33","author":"ET Koh","year":"1980","unstructured":"Koh ET, Chi MS, Lowenstein FW. Comparison of selected blood components by race, sex, and age. Am J Clin Nutr. 1980;33(8):1828\u201335.","journal-title":"Am J Clin Nutr"},{"key":"1191_CR58","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/ajcn\/16.6.492","volume":"16","author":"MA Lichtman","year":"1965","unstructured":"Lichtman MA, Hames CG, McDonough JR. Serum protein electrophoretic fractions among negro and White subject in Evans County, Georgia. Am J Clin Nutr. 1965;16:492\u2013508.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"1191_CR59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1002\/art.1780100306","volume":"10","author":"MA Lichtman","year":"1967","unstructured":"Lichtman MA, Vaughan JH, Hames CG. The distribution of serum immunoglobulins, anti-gamma-G globulins (\"rheumatoid factors\") and antinuclear antibodies in White and negro subjects in Evans County. Georgia. Arthritis Rheum. 1967;10(3):204\u201315.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1191_CR60","first-page":"91","volume":"31","author":"M Drent","year":"2014","unstructured":"Drent M, Cremers JP, Jansen TL, Baughman RP. Practical eminence and experience-based recommendations for use of TNF-alpha inhibitors in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31(2):91\u2013107.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-020-01191-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-020-01191-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,31]],"date-time":"2021-05-31T19:28:44Z","timestamp":1622489324000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-020-01191-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1186\/s12890-020-01191-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.17789\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.17789\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]},"assertion":[{"value":"7 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by University of Minnesota Institutional Review Board with protocol number 1501\u2009M60321 for collection of biospecimens and clinical data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}